Milken Institute
Showing 661–675 of 2094 transcripts.
- 46 min
China Opportunities: Insights from Business Leaders - Conference Call Series
Petra Freddi, Donald Lacey, Kai-Fu Lee, Cindy Mi, Don Lacey
The Milken Institute Asia Center hosted the seventh episode of "The World Post-COVID-19" series, moderated by Don Lacey and featuring Kai-Fu Lee and Cindy Mee to analyze the digital transformation in China's education and healthcare sectors. The discussion highlighted how pandemic-driven data surges have accelerated AI adoption, enabling rural learning via virtual tutors and healthcare leapfrogging through diagnostic tools, while noting a strategic investment shift from user-growth models to profitable AI integration in traditional industries. Furthermore, the panelists addressed geopolitical implications, observing that despite intensified US-China competition, China maintains AI self-sufficiency and is prioritizing global expansion in developing markets while advocating for technological over legislative solutions to digital risks.
- 1h 5m
How COVID-19 is Shaping the Future of Retail Banking - Conference Call Series
Michael Piwowar, Mary Mack, Daniel Sheehan, Chris Zingo, Mike Pivovar
Milken Institute experts and leaders from Wells Fargo, Professional Bank, and Finastra outlined a collaborative strategy to accelerate economic recovery through specific policy proposals and rapid operational pivots during the pandemic. These financial institutions successfully mobilized massive remote workforces, processed billions in Paycheck Protection Program loans, and deployed proprietary digital tools to sustain small business liquidity while ensuring cybersecurity. The panel concluded that the banking sector's future will rely on a hybrid model balancing digital efficiency with physical branch capabilities to maintain economic resilience.
- 33 min
The World Post COVID-19: Silver Linings for Business - Conference Call Series
Laura Deal Lacey, Oriel Morrison, Raj Ganguly, Magnus Grimeland, Chatri Sityodtong, Laura DeLacy
The Milken Institute convened a global webinar series featuring leaders from B Capital, Antler, and ONE Championship to analyze the unprecedented economic and societal shifts driven by the COVID-19 pandemic. These experts detailed how the crisis has halted traditional sectors while accelerating growth in digital health and education technology, prompting entrepreneurs to adopt a "warrior mentality" to secure supply chains and generate employment. The discussion further emphasized that while immediate survival strategies focus on short-term profitability, the long-term outlook predicts permanent structural changes in global governance and supply chain management.
- 1h 5m
Leadership in the New Normal: Business Leaders Respond to COVID-19 - Conference Call Series
Kevin Klowden, Jane Fraser, Barbara Humpton, Michael Milken, Mike Milken
At the Milken Institute session "Leadership in the New Normal," moderated by Kevin Clowden, panelists Jane Frazier of Citigroup, Barbara Humpton of Siemens USA, and Mike Milken analyzed the immediate business responses to the COVID-19 pandemic. Frazier detailed Citigroup's rapid shift to digital banking to support millions while maintaining access for vulnerable populations, whereas Humpton described Siemens' pivot to manufacturing critical medical supplies and establishing a "strategic digital twin reserve" for future crisis resilience. Milken provided a broader economic context, highlighting record-breaking vaccine development timelines and the necessity of public-private partnerships to address systemic inequalities and restore interdependent global supply chains.
- 44 min
The Impact of COVID-19 on Real Estate Investment - Conference Call Series
Peggy Sito, Hugh Andrew, Stuart Crow, Kenneth Gaw, Abhinav Ram Reddy, Laura DeLacy, Kenny Goh, Abhinav Reddy
This analysis details the severe contraction in Asia-Pacific real estate activity during early 2020, where transaction volumes fell 30% and specific sectors like hospitality and construction faced operational collapses due to pandemic restrictions. Despite current distress, investor sentiment remains cautiously optimistic with significant capital reserves poised to deploy once clarity emerges, while institutional players shift focus toward defensive assets like logistics, data centers, and medical facilities. Forecasts suggest a recovery timeline two to three times the duration of the lockdown, with markets possessing strong domestic fundamentals expected to rebound faster than those reliant on tourism and external trade.
- 8 min
Michael Milken on what Americans can do in fight against coronavirus
Michael Milken, Maria Bartiromo
Michael Milken characterizes the pandemic as a post-Pearl Harbor mobilization moment, directing the Milken Institute's resources toward six strategic pillars: education, prevention, treatment, cure, financial stability, and care. He outlines a data-driven roadmap that leverages cancer research insights, microbiome science, and accelerated testing to deploy antiviral therapies and immune-boosting treatments well before a vaccine becomes available. Concurrently, the initiative targets economic resilience by stabilizing small businesses and implementing interest-free digital lending to protect families, ultimately advocating for a permanent healthcare infrastructure rather than a cycle of reactive emergency measures.
- 21 min
Public Health Response to the Coronavirus
Dr. Christopher Morris of George Washington University assesses the early trajectory of the novel coronavirus outbreak, noting over 45,000 confirmed cases and 1,100 deaths while questioning the transparency of Chinese data reporting. He identifies two primary outcomes: the virus either becoming a severe seasonal pathogen or triggering a global pandemic, a scenario compounded by a lack of sustained funding for coronavirus research. Morris further highlights the WHO's enforcement delays and the urgent need for rapid diagnostic technologies, as vaccine development remains a minimum one-year process.
- 23 min
Lunch Program | Part 1: A Conversation with Alex Azar, Secretary, US Department HHS
The HHS, led by Secretary Alex Azar, outlined a 2017 healthcare strategy prioritizing affordability, patient choice, and quality through three pillars: financing reform, value-based payments, and targeted interventions. Key initiatives include a 5% decline in opioid overdose deaths driven by the $400 million Healing Communities Initiative, a shift from center-based to home dialysis via the KidneyX program, and a Medicare risk-sharing pilot affecting one-quarter of beneficiaries. Despite noting progress in reducing ACA premiums and expanding plan availability, the administration maintains that systemic flaws persist, aiming to replace fee-for-service models with incentives focused on prevention and long-term outcomes for the entire US population.
- 1h 0m
New Pathways to Neuroscience Breakthroughs
Rick Berke, Cara Altimus, Jeffrey Borenstein, Niranjan Bose, Johannes Streffer, Mike Belville, David Mongeau, Janet Knupp, Jing Lu, Ian Kramer, Anna McAllister
A panel of experts highlighted the critical gap in preventing and treating brain disorders despite projections that dementia cases will double over the next three decades. To address historical stagnation and corporate retreat, the discussion emphasized a strategic pivot toward diverse biological hypotheses, early biomarker detection, and philanthropic de-risking led by organizations like the Gates Foundation. This approach aims to overcome diagnostic delays and therapeutic failures by integrating real-world data, stem cell modeling, and patient-centric outcomes to accelerate the development of rapid-acting treatments.
- 1h 1m
A Journey to the Cutting Edge of Bioscience: Cancer as a Case Study
Margaret Anderson, Greg Friberg, Douglas Lowy, Fouad Namouni, Ellen Sigal, Nikhil Wagle, Angie Wilson, Sebastian Hermelin
Advancing from a generalized approach to highly personalized medicine, oncology has achieved unprecedented five-year survival rates for metastatic melanoma and long-term remission in lung cancer through immunotherapy and combination strategies. Despite these clinical successes, the sector faces significant hurdles including low clinical trial enrollment in community settings, fragmented electronic health record data, and ethical barriers to information sharing. To overcome these obstacles, stakeholders are leveraging artificial intelligence, patient-centered initiatives like "Count Me In," and predictive modeling to integrate community biospecimens and accelerate the development of functional cures.
- 35 min
MIc'd Up | Part 1: The Future of Education and Leadership
Deepak Chopra, Dave Asprey, VIKAS KHANNABISWAMY
Dr. Deepak Chopra outlines a transformative leadership framework defined by the LEADERS acronym, which redefines authority as a symbolic unification of collective dreams rather than bureaucratic power. He argues that true leadership requires a shift from ego-driven survival instincts to a state of flow, utilizing deep listening and emotional bonding to foster collective emergence. Furthermore, Chopra projects a future where AI and immersive VR technologies will revolutionize personalized health interventions and childhood development by bypassing traditional limitations to enhance intuition and creativity.
- 33 min
The New Age of Consumerism
Dan Murphy, Mohammed Alshaya, Mike Novogratz, Mohamed Alshayer
Mohamed Alshayer outlines Alshaya Group's $5 billion investment strategy in Saudi Arabia, emphasizing a pivot toward experiential retail and health sectors to capitalize on Vision 2030's rapid liberalization and shifting consumer behaviors. Concurrently, Mike Novogratz argues that Bitcoin's value rests on its narrative as a digital store of value, predicting institutional adoption will drive its valuation toward $10 trillion. The dialogue highlights how both legacy retail giants and emerging digital assets must reinvent their trust-based social constructs to survive in a market prioritizing speed, ethics, and immediate gratification.
- 39 min
A Conversation with Rajeev Misra
SoftBank's Vision Fund and Vision Fund 2 manage a diversified global portfolio of 88 investments, with recent strategic pivots toward Life Sciences and Financial Services utilizing AI to reduce healthcare costs and disrupt regulated lending. The firm distinguishes its value proposition through mid-stage capital, extensive ecosystem synergies like cross-selling between Grab and Ping, and operational support derived from SoftBank Mobile, which drove a portfolio valuation surge from $240 billion to approximately $300 billion. As the funds mature, the team has shifted focus to 75% portfolio management, celebrating eight IPOs and major exits including Uber and Flipkart while preparing for the economic impact of 5G adoption via the Sprint-Deutsche Telekom merger.
- 34 min
A Conversation with Strive Masiyiwa and Michael Milken
Strive Masiyiwa, Michael Milken
With Africa's population projected to reach 4 billion by 2100 and 12 million young entrants joining the workforce annually, the continent faces a critical imperative to modernize its fragmented economy and address high unemployment rates like the 29% in South Africa. Global tech giants and investors are capitalizing on unique innovations such as mobile money and blockchain to unify 54 currencies, while infrastructure projects connect the continent from Cape Town to Cairo alongside rapid 5G deployment. Strategic partnerships led by figures like Strive Maseiwa aim to train government leaders and expand private enterprise networks, positioning Africa as a primary future market despite capital shortages and the need to replace nearly 500 million traditional jobs.
- 29 min
Mic'd Up - Part 2:Genomics & the Future of Medicine
Rick Berke, Phil Febbo, Anamika Mehta, Rakesh Suri
The event details how advanced viral defense mechanisms, culturally attuned facility designs, and rapidly declining genomic sequencing costs are reshaping clinical precision medicine, with specific case studies highlighting Cleveland Clinic Abu Dhabi's successful integration of these technologies. Key speakers analyze the friction caused by fragmented U.S. payers and electronic health records while contrasting these challenges with the streamlined adoption seen in the UK and the UAE's population-specific cancer initiatives. The discussion concludes with a strategic roadmap for the next decade that emphasizes decentralized care, robust data privacy protocols, and AI-driven analytics to transform genomic insights into actionable, personalized patient outcomes.